Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $5.8850 (3.52%) ($5.8850 - $5.8850) on Wed. Jun. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.97% (three month average) | RSI | 63 | Latest Price | $5.8850(3.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.9% a day on average for past five trading days. | Weekly Trend | ATRA advances 3.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(39%) IBB(37%) ARKK(35%) ARKG(34%) XAR(32%) | Factors Impacting ATRA price | ATRA will decline at least -2.485% in a week (0% probabilities). VIXM(-37%) VXX(-26%) UNG(-24%) USO(-19%) XOP(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.485% (StdDev 4.97%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.33(10.41%) | 10 Day Moving Average | $5.18(13.61%) | 20 Day Moving Average | $5.17(13.83%) | To recent high | -40.3% | To recent low | 25.5% | Market Cap | $437m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |